Rosie joined the Dehns Brighton office in October 2020 after completing a Master’s degree (Distinction) at the University of Southampton. Her dissertation classified variants in congenital heart disease patients to investigate the presence of undiagnosed primary ciliopathies.
Rosie’s undergraduate degree, at the University of Cambridge, focused on Genetics in the final year, with a project involving CRISPR/Cas9 mutagenesis of Drosophila melanogaster lines. The project aimed to determine the effect of Plp mutagenesis on female fertility and egg chamber morphology.
She is a Technical Assistant in the Dehns Biotechnology Group.